{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T02:45:47Z","timestamp":1782528347337,"version":"3.54.5"},"reference-count":15,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>We conducted a survey to evaluate HIV pre\u2010exposure prophylaxis (PrEP) practices in a European clinical research network on HIV, hepatitis, and global infectious diseases (NEAT ID).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An online survey comprising 22 questions was sent via a secure electronic tool to the investigating physician of each of the 342 NEAT ID study centres across 15 European countries in November 2020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 50 sites from 12 countries responded (15% response rate). Most sites were in Western Europe, two were in Poland, and one was in Hungary. Of the responding sites, 45 provided PrEP services for a total of 27\u2009416 PrEP users, with 1361 new PrEP initiators each month. These centres supplied PrEP for men who have sex with men (100%), people who inject drugs (84%), sex workers (84%), women (62%), and transgender women (31%). PrEP persistence after 1\u2009year was &gt;90%, 75%\u201390%, and 40%\u201375% in 17, 24, and 4 centres, respectively. In total, 32\/45 (71%) centres reported strong community\u2010based organization commitment at their site, and 15\/45 (33%) centres developed task\u2010shifting processes to deliver PrEP through nurses (11\/15), pharmacists (5\/15), and key\u2010population peers (2\/15). The biggest barriers to implementation of PrEP were low awareness of and knowledge about PrEP (47%), unwillingness to disclose sexual identity or at\u2010risk behaviour (36%), and lack of administrative support (29%). Of the 45 centres, 32 (71%) have already been involved in PrEP research and 43 (96%) were interested in participating in such studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The few NEAT ID centres that responded to the survey showed disparities in PrEP deployment and practices despite a common interest in participating in research in this field.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.13580","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T02:01:11Z","timestamp":1701482471000},"page":"353-360","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["<scp>HIV<\/scp> pre\u2010exposure prophylaxis services, provision, and delivery in the European treatment network of <scp>HIV<\/scp>, hepatitis and global emerging infectious diseases (<scp>NEAT ID<\/scp>)"],"prefix":"10.1111","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-4347","authenticated-orcid":false,"given":"Geoffroy","family":"Liegeon","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases and Global Health University of Chicago Medicine  Chicago Illinois USA"},{"name":"Department of Infectious Diseases Saint Louis and Lariboisi\u00e8re Hospitals  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Duffy","sequence":"additional","affiliation":[{"name":"Research Organisation Kings Cross  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Brooks","sequence":"additional","affiliation":[{"name":"Research Organisation Kings Cross  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Honour","sequence":"additional","affiliation":[{"name":"Research Organisation Kings Cross  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Pozniak","sequence":"additional","affiliation":[{"name":"Department of HIV Medicine Chelsea &amp; Westminster Hospital NHS Foundation Trust  London UK"},{"name":"Department Clinical Research London School of Hygiene &amp; Tropical Medicine  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Molina","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Saint Louis and Lariboisi\u00e8re Hospitals  Paris France"},{"name":"INSERM UMR 944  Paris France"},{"name":"Paris Cit\u00e9 University  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the NEAT ID PrEP survey group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,12]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30215-7"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506273"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"e_1_2_8_5_1","unstructured":"ECDC Evidence Brief.Pre\u2010exposure prophylaxis for HIV prevention in Europe and Central Asia Monitoring implementation of the Dublin Declaration on Partnership to fight HIV\/AIDS in Europe and Central Asia \u2013 2022 progress report. Stockholm.2023. Available athttps:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/HIV\u2010pre\u2010exposure\u2010prophylaxis\u2010evidence\u20102019_0.pdf2023."},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.41.1900598"},{"key":"e_1_2_8_7_1","unstructured":"European Centre for Disease Prevention and Control World Health Organization.WHO Regional Office for Europe European Centre for Disease Prevention and Control. HIV\/AIDS surveillance in Europe 2022\u20132021 data. Copenhagen.2022. Available athttps:\/\/data.europa.eu\/doi\/10.2900\/818446"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ664"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010122"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12960"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jve.2020.100026"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01295-0"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12641"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13451"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30725-9"},{"key":"e_1_2_8_16_1","unstructured":"MolinaJM BersotB LambertA et al.ANRS 174 DOXYVAC: an open\u2010label randomized trial to prevent STIs in MSM on PrEP. Conference on retroviruses and opportunistic infections.2023Seattle. Abstract 119."}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.13580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T07:16:39Z","timestamp":1709622999000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.13580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1111\/hiv.13580"],"URL":"https:\/\/doi.org\/10.1111\/hiv.13580","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"2023-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}